Martin Olov Vidaeus

Martin Olov Vidaeus is a declared insider at 3 companies; the most frequent names are Redwood Pharma, Redwood Pharma AB and Redwood Pharma AB (publ). We count 6 filings; the first trade dates from 18 March 2020 and the latest from 5 September 2023.

On the open market, the record shows 4 purchases worth €8,836 and 2 sales. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2023 to date brings no purchases and 2 sales.

In size, the median ticket on the buying side is €2,242. No cluster: in 4 purchases, no other insider of the company bought within 30 days.

Most recently, on 8 September 2023, the filings show an open-market sale in Redwood Pharma AB. The clock since the last published purchase (16 November 2021) now reads 1,818 days. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.